Multidrug resistance in Cancer: Pharmacological Strategies from Basic Research to Clinical Issues
More than 40 years ago, the observation that doxorubicin-resistant tumor cells were cross-resistant to several structurally different anticancer agents was the first step in the discovery of P-glycoprotein (P-gp). P-gp belongs to the superfamily of ATP-binding cassette (ABC) transporters;its overexp...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Frontiers Media SA
2021
|
| Subjects: | |
| Online Access: | 19523 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Multidrug resistance in Cancer: Pharmacological Strategies from Basic Research to Clinical Issues
- Natural Products for Cancer Prevention and Therapy
- Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
- MicroRNAs: Novel Biomarkers and Therapeutic Targets for Human Cancers
- Computational and Experimental Approaches in Multi-Target Pharmacology
- Ways to improve tumor uptake and penetration of drugs into solid tumors
- Update in Pediatric Neuro-Oncology